101583-3

LOINC 2.82

ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative

ESBL cft to cft-clav IC rto Bd Pos Imp

Component

  • Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio

Specimen / system

  • Bld.pos growth

Class

  • ABXBACT

Property

  • Imp

Scale

  • Ord

Method

  • Based on lab data

Related names

  • ANTIBIOTIC SUSCEPTIBILITIES; B; Betalactamase; B-Lactamase; Bld Pos; Blood; c305; Ceftaz; Clav; Clavate; Clavu; Clavul; Clavulanic; Clavulanic acid; ESBL by ceftaz to ceft-clav IC rto; Forj; Fortaz; from lab data; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tazicef; Tazj; WB; Whole blood

Index terms

  • ANTIBIOTIC SUSCEPTIBILITIES
  • B
  • B-Lactamase
  • Betalactamase
  • Bld Pos
  • Blood
  • c305
  • Ceftaz
  • Clav
  • Clavate
  • Clavu
  • Clavul
  • Clavulanic
  • Clavulanic acid
  • ESBL by ceftaz to ceft-clav IC rto
  • Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio
  • Forj
  • Fortaz
  • from lab data
  • Impression
  • Impression/interpretation of study
  • Impressions
  • Interp
  • Interpretation
  • Ordinal
  • Point in time
  • QL
  • Qual
  • Qualitative
  • Random
  • Screen
  • Tazicef
  • Tazj
  • WB
  • Whole blood